Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 08:00 ET | Source: Cingulate Inc.

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products...
October 23, 2025 16:45 ET | Source: Cingulate Inc.

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products...
October 09, 2025 08:00 ET | Source: Beghou

Introducing the Beghou Arc™ Platform, Helping Life Sciences Companies Adapt Faster, Execute with Precision, and Drive Stakeholder Trust

Beghou Arc is a flexible, connected commercialization platform designed to help life sciences teams launch and grow more effectively in dynamic markets.
September 30, 2025 09:00 ET | Source: ACTion Battery Technologies, Inc.

ACT-ion to Establish Advanced Cathode Pilot Plant in Carrollton, Texas

ACT-ion Battery Technologies, Inc. ("ACT-ion") today announced it has signed a lease for a new facility at 1200 Tappan Circle in Carrollton, Texas.
September 29, 2025 08:00 ET | Source: Lumanity

Lumanity Introduces Groundbreaking Value Framework to Transform Biopharma Commercialization

Lumanity announces the launch of its new Value Inflection Point framework to help biopharma accelerate access.
September 17, 2025 08:45 ET | Source: Cingulate Inc.

Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment

KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
July 10, 2025 11:00 ET | Source: Boston Metal

Boston Metal Announces $51 Million Convertible Note to Accelerate Scale-Up of Critical Metals Plant and Capitalize on Recent Steel Technology Milestone

Boston Metal announced it has raised $51 million in a convertible note investment to accelerate the scale-up of its critical metals plant.
July 09, 2025 08:00 ET | Source: Cingulate Inc.

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

KANSAS CITY, Kan., July 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
May 29, 2025 08:00 ET | Source: Beghou Consulting

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities
May 14, 2025 08:00 ET | Source: Cingulate Inc.

FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301

Pre-NDA Minutes from April 2, 2025, Meeting Received NDA Submission Planned this Summer KANSAS CITY, Kan., May 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical...